SCHEMBL3868872

SCHEMBL3868872

CC1CCNCc2nnc(C(F)(F)F)n21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3868874 1.00
SCHEMBL5935841 0.84 HTR2A (0.31)
SCHEMBL16790030 0.71
SCHEMBL16790029 0.71 PARP1 (0.33)
SCHEMBL22536515 0.69 PDK1 (0.41)
SCHEMBL22536517 0.69 PDK1 (0.41)
SCHEMBL212149 0.68 MGLL (0.36)
SCHEMBL4431123 0.68 HTR2C (0.30)
SCHEMBL3594511 0.68 DPP4 (0.39)
SCHEMBL18436618 0.68 PDK1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1624874-B1 3-AMINO-4-PHENYLBUTANOIC ACID DERIVATIVES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO INC (US) 2009-11-04 EP disclosed
US-7560455-B2 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes MERCK & CO., INC. (US) 2009-07-14 US disclosed
US-20060258646-A1 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes MERCK SHARP & DOHME LLC 2006-11-16 US disclosed